Hotel Information:
Hyatt Arlington
Course Location:
PERI Training Facility
1616 N. Fort Myer Drive, Suite 1430
Arlington, VA 22209
Telephone: (703) 276-0178
Hotel rooms available at:
Hyatt Arlington
1325 Wilson Boulevard
Arlington, VA
Reservations: 800-233-1234 Direct #: 703-525-1234
Fax Number: (703) 908-4679
Discounted Hotel Room Rate: $209 Deadline to Receive Discounted Rate: 10/9/2006
Course will be held at PERI Training Facility. 1616 N. Fort Myer Dr. Suite 1430. Arlington, VA 22209
Rate: $
209
Deadline for Group Rate:
2006-10-09
Hotel Policy
|
Registration Rate:
$1,495.00 Register by 09/20/06
$1,695.00 Register after 09/20/06
Cancellation Date: 10/18/06 (Cancellation fee is determined by date cancelled.)
Course Completed
Registration Policy
Continuing Education Credit:
ACPE:
708-000-05-004-L01 (1.775 CEU)
Initial Release Date:
12/5/05
CBRN:
N/A
CME:
17.75 Hours of Category 1 Credit
VNA:
04-04-05 21.30 Contact Hours
Continuing Education Policy
|
| |
Course Description:
View the Agenda
This course will provide an overview of cardiovascular disease and new advances in drug development. Topics will include basic anatomy and physiology associated with congestive heart failure, hypertension, coronary and peripheral artery disease, thrombosis and anticoagulation, and cardiac arrhythmia from both clinical and drug development perspectives.
|
Who Should Attend:
This course is directed towards individuals associated with cardiovascular drug development. This will include project managers, clinical monitors, directors of clinical research and development, business development and decision makers in pharmaceutical R&D.
|
Educational Objectives:
Upon completion of this course, participants should be able to:
- Describe the basic anatomy, physiology, epidemiology, and diagnosis of the cardiovascular disease
- Discuss new therapeutic approaches and key clinical trials
- Identify issues involved in designing and analyzing cardiovascular clinical trials
- Gain an understanding of the regulatory issues related to cardiovascular drug development
- Discuss drug safety issues and how to monitor them in clinical trials
- Interact with experts from the FDA and the pharmaceutical industry
|
Key Topics:
- Cardiovascular Disease: Overview of Basic Anatomy and Physiology
- New Therapeutic Approaches to Cardiovascular Disease Management
Congestive Heart Failure , Hypertension, Anticoagulation, Coronary Artery Disease and Cardiac Arrhythmia
- Design of Cardiovascular Clinical Trials
- Statistical Considerations
- Drug Safety and Monitoring
- Regulatory Considerations
|
|
Course Director(s):
To Be Announced
|
|
Contact Course Manager:
Course Manager
|
| |
|
|
|
PERI reserves the right to change agenda
items and instructors without notice to accommodate
situations beyond its control.
|
